FOXO1 and neoplasm: This could be explained by the higher percentage of FT-negative tumor in our series (25%) compared to that (14%) of Ludmir et al. Indeed, in univariate analysis, tumor expression of a PAX3/PAX7-FOXO1 FT was a significant risk factor for relapse (p = 0.004).